This article provides insights into recent insider stock purchases for penny stocks, highlighting the buying activities of executives at ONE Group Hospitality, Solo Brands, and Xeris Biopharma. These transactions could signal insider confidence in the companies’ prospects and are worth noting for investors considering these stocks.
Investing in speculative penny stocks carries significant risks, but it can also offer opportunities for potential gains. This article highlights several overlooked penny stocks that have drawn attention due to their unique value propositions and growth prospects.
Several notable insider transactions were recently observed in penny stocks. Sherwood Revocable Trust, a 10% owner of Barnwell Industries, purchased a significant number of shares at $2.80 per share. The company is involved in the acquisition, development, production, and sale of oil and natural gas. Meanwhile, Mobile Infrastructure Corporation’s CEO, Manuel Chavez III, acquired shares at $3.39 each. The company is expected to release its first-quarter 2024 earnings results on May 15, 2024. Furthermore, Galectin Therapeutics Inc.’s Director, Kevin D Freeman, bought shares at an average price of $2.98 per share. HC Wainwright & Co. analyst recently reiterated a ‘Buy’ rating for Galectin Therapeutics with a price target of $11.
